Dr. Sotomayor serves as the vice president and executive director of the Tampa General Hospital Cancer Institute, leading a team dedicated to advanced cancer care within one of Florida’s premier academic medical centers. An internationally recognized pioneer in cancer immunology and immunotherapy, he has published over 130 influential research papers, contributing to significant advancements in lymphoma treatment. Under his leadership, the cancer institute has expanded its clinical and research services, earning accolades as one of the nation’s leading oncology programs from organizations like U.S. News and World Report. His initiatives include the implementation of cutting-edge therapies such as CAR-T cell treatment and advanced radiation technologies like the CyberKnife system. Dr. Sotomayor actively participates in various prestigious medical organizations, serving as chair of the Lymphoma Research Foundation Mantle Cell Lymphoma Consortium and holding key positions in multiple committees related to cancer research.
